# Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression

> **NCT07211438** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Centre for Addiction and Mental Health** · enrollment: 40 (estimated)

## Conditions studied

- Treatment-Resistant Depression

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT07211438
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211438, "Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07211438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*